FDA Commissioner Robert Califf, M.D., M.A.C.C., will discuss in regards to the company’s essential priorities on Friday, April 29, on the Affiliation of Well being Care Journalists’ first convention since 2019. His remarks will likely be adopted by a question-and-answer session.
Dr. Califf served as FDA commissioner on the finish of the Obama administration. In returning to the publish, he emphasised a necessity for the FDA to assist counter misinformation about science that he says has develop into more and more prevalent.
“These sorts of distortions and half-truths that discover their method into the general public area do huge hurt, each by main individuals to habits that’s detrimental to their well being and by inflicting them to eschew interventions that will enhance their well being,” Califf stated in a memo to workers.
Classes from the pandemic, the well being menace posed by e-cigarettes, ache administration with out habit, and the pressures on the drug approval course of may even probably be a part of the dialog.
Califf was confirmed earlier this 12 months because the twenty fifth commissioner of the FDA — his second stint, having served in 2016. Earlier than assuming the position at the moment, he was FDA’s Deputy Commissioner for Medical Merchandise and Tobacco.
He has had an extended profession as a doctor, researcher, and chief in science and medication and is a nationally acknowledged skilled in cardiovascular medication, well being outcomes analysis, well being care high quality and scientific analysis. He’s additionally a frontrunner within the rising discipline of translational analysis, which is vital to making sure that advances in science translate into medical care.
Previous to rejoining the FDA in 2022, Califf was head of medical technique and senior advisor at Alphabet Inc., contributing to technique and coverage for its well being subsidiaries Verily Life Sciences and Google Well being. He joined Alphabet in 2019, after serving as a professor of drugs and vice chancellor for scientific and translational analysis at Duke College. He additionally served as director of the Duke Translational Medication Institute and was the founding director of the Duke Scientific Analysis Institute.
Califf is a graduate of Duke College Faculty of Medication. He accomplished a residency in inside medication on the College of California, San Francisco and a fellowship in cardiology at Duke.